FarrellOMendelsohnMD

Cardiology • Birmingham, AL

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Join to view full profile

Dr. Mendelsohn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mendelsohn's full profile

Already have an account?

Office
801 Princeton Ave Sw
Sute 706
Birmingham, AL 35211
Phone+1 205-780-4330

Fax+1 205-780-7775

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1995 - 1999
Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1995
Johns Hopkins University School of MedicineClass of 1992

Certifications & Licensure

AL State Medical License 1998 - 2024
NC State Medical License 1995 - 2000
VA State Medical License 1997 - 2000
National Board of Physicians and Surgeons Cardiovascular Disease
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Interventional Cardiology

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

ALD-301 for Critical Limb Ischemia, Randomized Trial Start of enrollment: 2006 Oct 01
Completed
Phase 1, Phase 2
Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia Start of enrollment: 2012 Jun 01
Completed
Phase 2
An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) Start of enrollment: 2013 Feb 20
Completed
Phase 2
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure Start of enrollment: 2013 Oct 01
Unknown status
Phase 1, Phase 2
A Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension Start of enrollment: 2017 Mar 22
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

79 citations
Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction Phase I Clinical Study
Marc S. Penn, Stephen G. Ellis, Sanjay Gandhi, Adam Greenbaum, Zachary Hodes
Circulation Research. 2012-01-20
171 citations
Primary renal artery stenting: characteristics and outcomes after 363 procedures.
Robert J. Lederman, Farrell O. Mendelsohn, Renato Hideo Nakagawa Santos, Harry R. Phillips, Richard S. Stack
American Heart Journal. 2001-08-01
105 citations
An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure
Marc S. Penn, Farrell O. Mendelsohn, Gary L. Schaer, Warren Sherman, Maryjane Farr
Circulation Research. 2013-03-01

Professional Memberships

American College of Cardiology - ACC
Member